期刊文献+

杨梅黄酮减弱MPP^+诱导的MES23.5细胞的细胞毒性(英文)

Myricetin Attenuates MPP^+-induced Cytotoxicity in MES23.5 Cells
原文传递
导出
摘要 目的:探讨杨梅黄酮对MPP+处理的MES23.5细胞的保护作用。方法:实验分为空白对照组,MPP+处理组,MPP+和杨梅黄酮共处理组,分别处理MES23.5细胞24h后,应用Hoechst 33258染色观察各组细胞细胞核形态的改变,应用RT-PCR技术观察Bcl-2和Bax mRNA表达的改变。结果:杨梅黄酮能明显抑制MPP+引起的MES23.5细胞核固缩,核碎裂等形态学的改变,杨梅黄酮还可以对抗MPP+处理造成的MES23.5细胞的Bcl-2/Bax比率的降低。结论:杨梅黄酮对MPP+处理的MES23.5细胞具有保护作用。 To investigate the neuroprotective effect of myricetin on 1-methyl-4-phenylpyridinium (MPP^+)-treated MES23.5 cells. Methods: MES23.5 cells were treated with vehicle, MPP^+, MPP^+ and myricetin for 24h respectively. By Hoechst staining and RT-PCR, the nuclear morphological changes and the Bel-2 and Bax mRNA levels were investigated. Results: The results showed that myricetin treatment significantly attenuate MPP^+-induced cell apoptosis. MPP^+ treatment induced decrease of Bcl-2/Bax mRNA ratio was also inhibited by myricetin. Conclusion: Myricetin may protect against MPP^+-induced cytotoxicity in MES23.5 cells.
出处 《现代生物医学进展》 CAS 2011年第10期1830-1833,共4页 Progress in Modern Biomedicine
基金 Natural Science Foundation of China(30800353) the Bureau of Science and Technology of Qingdao(09-1-1-29-nsh)~~
关键词 杨梅黄酮 MPP^+ 凋亡 MES23.5 CELLS Myrieetin MPP^+ Apoptosis MES23.5 cells
  • 相关文献

参考文献20

  • 1Mandel S, Grunblatt E, Youdim M. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease [J]. J Neural Transm Suppl, 2000, (60):117-124.
  • 2Linazasoro GJ. Neuroprotection in Parkinson's disease: love story or mission impossible [J] Expert Rev Neurother 2002, 2:403-416.
  • 3Mcnaught KS, Belizaire R, Jenner P, et al. Selective loss of20S prote - asome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease [J]. Neurosci Lett 2002, 326:155-158.
  • 4Anantharam V, Lehrmann E, Kanthasamy A, et al. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease [J]. Neurochem hat, 2007, 50:834-847.
  • 5Gardoni F, Diluca M. New targets for pharmacological intervention in the glutamatergic synapse [J]. Eur J Pharmacol 2006, 545:2-10.
  • 6Moldzio R, Radad K, Duvigneau JC, et al. Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture [J]. J Neural Transm, 2006,113:1095-1105.
  • 7Koprich JB, Reske NC, Mithal P, et al. Neuroinflammation mediated b y IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease [J]. J Neuroinflammation 2008,5:8-14.
  • 8Thomas T, Tirnmer M, Cesnulevicius K, et al. MAPKAP kinase 2-def- iciency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease [J]. J Neurochem, 2008,105:2039-2052.
  • 9Hladovec J. Antithrombotic effects of some flavonoids alone and combinedwithacetylsalicylic acid [J]. Arzneimittel for schung, 1977,27:1989- 1992.
  • 10Molina JMF, Sanchez-reus MI, Benedi J. Effect of fraxetin and myri - cetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine [JJ. Eur J Pharmacol, 2003, 472:81-87.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部